Lista de obras - Soni Savai Pullamsetti - Dominio Público Uruguay

5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure

artículo científico publicado en 2015

A Combination Hybrid-Based Vaccination/Adoptive Cellular Therapy to Prevent Tumor Growth by Involvement of T Cells

artículo científico publicado en 2007

A FOX-Like Mechanism Regulating Lung Fibroblasts - Are We Getting There?

artículo científico publicado en 2020

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

scientific article published on 13 May 2019

Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis

artículo científico publicado en 2015

Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension

artículo científico publicado en 2014

Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension

artículo científico publicado en 2004

Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

scientific article published on 30 June 2020

CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension

artículo científico publicado en 2020

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.

artículo científico publicado en 2008

Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.

artículo científico publicado en 2016

Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock

artículo científico publicado en 2006

Effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculation in endotoxinemic rats.

artículo científico publicado en 2012

Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.

artículo científico publicado en 2012

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice

artículo científico publicado en 2010

Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

scientific article published on 26 November 2020

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives

artículo científico publicado en 2016

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer

artículo científico publicado en 2017

Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer

artículo científico publicado en 2009

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.

artículo científico publicado en 2009

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.

artículo científico publicado en 2008

Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system

artículo científico publicado en 2022

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis

artículo científico publicado en 2018

Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.

artículo científico publicado en 2011

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

artículo científico publicado en 2013

Hybrid-Primed Lymphocytes and Hybrid Vaccination Prevent Tumor Growth of Lewis Lung Carcinoma in Mice

artículo científico publicado en 2006

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β.

artículo científico publicado en 2011

Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes

artículo científico

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs

artículo científico publicado en 2007

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma

artículo científico publicado en 2015

Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension

artículo científico publicado en 2012

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

artículo científico publicado en 2005

Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2007

Inflammation, immunological reaction and role of infection in pulmonary hypertension.

artículo científico publicado en 2011

Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension

artículo científico publicado en 2005

Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration

artículo científico publicado en 2005

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension

artículo científico publicado en 2011

Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia.

artículo científico publicado en 2008

Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function

artículo científico publicado en 2017

Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk

artículo científico publicado en 2017

Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer

artículo científico publicado en 2015

Matrix metalloproteinases and their inhibitors in pulmonary hypertension

artículo científico

Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts

artículo científico publicado en 2005

Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

artículo científico publicado en 2016

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment

scientific article published on 01 September 2020

Metastasis-associated protein 2 represses NF-ƙB to reduce lung tumor growth and inflammation

scientific article published on 14 August 2020

MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts

artículo científico publicado en 2013

Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients

artículo científico publicado en 2021

Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension.

artículo científico publicado en 2016

Novel and emerging therapies for pulmonary hypertension

artículo científico publicado en 2014

PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells.

artículo científico publicado en 2016

Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition.

artículo científico publicado en 2007

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

artículo científico publicado en 2019

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy

artículo científico publicado en 2007

Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling

artículo científico publicado en 2011

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.

artículo científico publicado en 2010

Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

artículo científico publicado en 2014

Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer

artículo científico publicado en 2020

Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury

artículo científico publicado en 2017

Reversal of experimental pulmonary hypertension by PDGF inhibition

artículo científico publicado en 2005

Role of Src tyrosine kinases in experimental pulmonary hypertension.

artículo científico publicado en 2012

Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

artículo científico publicado en 2009

Role of the phosphatase PTEN in early vascular remodeling.

artículo científico publicado en 2013

Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension

artículo científico publicado en 2008

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma

artículo científico publicado en 2020

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension

artículo científico publicado en 2019

Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats

artículo científico publicado en 2010

The emerging role of epigenetics in pulmonary hypertension

artículo científico publicado en 2016

The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis

artículo científico publicado en 2011

The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.

artículo científico publicado en 2009

Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

artículo científico publicado en 2020

Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs

artículo científico publicado en 2016

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer.

artículo científico publicado en 2010

Vascular Stiffness and Mechanotransduction: Back in the Limelight

artículo científico publicado en 2017

Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension: What More Single-cell Omics Can Offer

artículo científico publicado en 2020

[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016].

artículo científico publicado en 2016

[Pulmonary arterial hypertension--a disease of the immune system?].

artículo científico publicado en 2014

cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.

artículo científico publicado en 2011

miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.

artículo científico publicado en 2016

Lista de obras de Soni Savai Pullamsetti

5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure

A Combination Hybrid-Based Vaccination/Adoptive Cellular Therapy to Prevent Tumor Growth by Involvement of T Cells

A FOX-Like Mechanism Regulating Lung Fibroblasts - Are We Getting There?

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis

Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension

Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension

Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.

Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.

Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock

Effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculation in endotoxinemic rats.

Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice

Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer

Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.

Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis

Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

Hybrid-Primed Lymphocytes and Hybrid Vaccination Prevent Tumor Growth of Lewis Lung Carcinoma in Mice

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β.

Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma

Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension.

Inflammation, immunological reaction and role of infection in pulmonary hypertension.

Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension

Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension

Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia.

Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function

Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk

Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer

Matrix metalloproteinases and their inhibitors in pulmonary hypertension

Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts

Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment

Metastasis-associated protein 2 represses NF-ƙB to reduce lung tumor growth and inflammation

MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts

Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients

Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension.

Novel and emerging therapies for pulmonary hypertension

PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells.

Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition.

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy

Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.

Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer

Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury

Reversal of experimental pulmonary hypertension by PDGF inhibition

Role of Src tyrosine kinases in experimental pulmonary hypertension.

Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

Role of the phosphatase PTEN in early vascular remodeling.

Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension

Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats

The emerging role of epigenetics in pulmonary hypertension

The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis

The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.

Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer.

Vascular Stiffness and Mechanotransduction: Back in the Limelight

Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension: What More Single-cell Omics Can Offer

[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016].

[Pulmonary arterial hypertension--a disease of the immune system?].

cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.

miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.